Patent · US Active

Aryl dihydropyridinones and piperidinone MGAT2 inhibitors

US10369140B2 · kind B2 · utility

2Cited by

10References

17Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

Huji Turdi · Yardley, US
Jon J. Hangeland · Levittown, US
R. Michael Lawrence · Yardley, US
Saleem Ahmad · Wall, US
Wei Meng · Pennington, US
Robert Paul Brigance · Levittown, US
Pratik Devasthale · Plainsboro, US
Guohua Zhao · Princeton, US

Key dates

Filing date	Jan 11, 2018
Grant date	Aug 6, 2019
Priority date	—
Expiry date	Jan 11, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07F9/59
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.